A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain
Clinical trial NCT05892068 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05892068
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-09
- Primary completion
- 2028-05-09
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.